1. Home
  2. ELAN

as 11-15-2024 12:34pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Founded: 1954 Country:
United States
United States
Employees: N/A City: GREENFIELD
Market Cap: 6.3B IPO Year: 2018
Target Price: $17.00 AVG Volume (30 days): 4.7M
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.41 EPS Growth: N/A
52 Week Low/High: $11.20 - $18.80 Next Earning Date: 11-07-2024
Revenue: $4,454,000,000 Revenue Growth: 1.99%
Revenue Growth (this year): 2.22% Revenue Growth (next year): 2.77%

ELAN Daily Stock ML Predictions

Stock Insider Trading Activity of Elanco Animal Health Incorporated (ELAN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Harrington Michael J ELAN Director Aug 22 '24 Buy $14.85 3,500 $51,974.30 81,094

Share on Social Networks: